A new weapon is emerging in the war against pancreatic cancer

U.S. and Japanese researchers have come up with a novel, image-based way to track stem cell signals so as to halt pancreatic cancer in its tracks.

Because reporter activity of the stem-cell gene Msi can be visualized by live imaging, “these models can be used to track cancer stem cells within the tumor microenviroment,” explained Tannishtha Reya, PhD, of UC-San Diego School of Medicine.

This may provide “a real-time view of cancer growth and metastasis,” she added, and serve “as a platform to test new drugs that may be better able to eradicate resistant cells.”

The newsroom at UC-San Diego Health has the story: 

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.